These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 9434860)

  • 41. Phenytoin embryotoxicity: role of enzymatic bioactivation in a murine embryo culture model.
    Shanks MJ; Wiley MJ; Kubow S; Wells PG
    Teratology; 1989 Oct; 40(4):311-20. PubMed ID: 2814893
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of thalidomide teratogenicity by acetylsalicylic acid: evidence for prostaglandin H synthase-catalyzed bioactivation of thalidomide to a teratogenic reactive intermediate.
    Arlen RR; Wells PG
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1649-58. PubMed ID: 8667234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Deficient DNA repair exacerbates ethanol-initiated DNA oxidation and embryopathies in ogg1 knockout mice: gender risk and protection by a free radical spin trapping agent.
    Miller-Pinsler L; Wells PG
    Arch Toxicol; 2016 Feb; 90(2):415-25. PubMed ID: 25354798
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro bioactivation of phenytoin to a reactive free radical intermediate by prostaglandin synthetase, horseradish peroxidase, and thyroid peroxidase.
    Kubow S; Wells PG
    Mol Pharmacol; 1989 Apr; 35(4):504-11. PubMed ID: 2539558
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A developmental role for ataxia-telangiectasia mutated in protecting the embryo from spontaneous and phenytoin-enhanced embryopathies in culture.
    Bhuller Y; Wells PG
    Toxicol Sci; 2006 Sep; 93(1):156-63. PubMed ID: 16790486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Copper redox-dependent activation of 2-tert-butyl(1,4)hydroquinone: formation of reactive oxygen species and induction of oxidative DNA damage in isolated DNA and cultured rat hepatocytes.
    Li Y; Seacat A; Kuppusamy P; Zweier JL; Yager JD; Trush MA
    Mutat Res; 2002 Jul; 518(2):123-33. PubMed ID: 12113763
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulation of embryonic glutathione reductase and phenytoin teratogenicity by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU).
    Wong M; Wells PG
    J Pharmacol Exp Ther; 1989 Jul; 250(1):336-42. PubMed ID: 2746506
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolism of phenytoin and covalent binding of reactive intermediates in activated human neutrophils.
    Mays DC; Pawluk LJ; Apseloff G; Davis WB; She ZW; Sagone AL; Gerber N
    Biochem Pharmacol; 1995 Jul; 50(3):367-80. PubMed ID: 7646538
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathy.
    Ornoy A
    Reprod Toxicol; 2007 Jul; 24(1):31-41. PubMed ID: 17548185
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of phenytoin bioactivation and teratogenicity by dietary n-3 fatty acids in mice.
    Kubow S
    Lipids; 1992 Sep; 27(9):721-8. PubMed ID: 1487972
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Free radicals, metals and antioxidants in oxidative stress-induced cancer.
    Valko M; Rhodes CJ; Moncol J; Izakovic M; Mazur M
    Chem Biol Interact; 2006 Mar; 160(1):1-40. PubMed ID: 16430879
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antioxidant and GSH-related enzyme response to a single teratogenic exposure to the anticonvulsant phenytoin: temporospatial evaluation.
    Amicarelli F; Tiboni GM; Colafarina S; Bonfigli A; Iammarrone E; Miranda M; Di Ilio C
    Teratology; 2000 Aug; 62(2):100-7. PubMed ID: 10931507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synergistic DNA damage and lipid peroxidation in cultured human white blood cells exposed to 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone and ultraviolet A.
    Chuang CH; Hu ML
    Environ Mol Mutagen; 2006 Mar; 47(2):73-81. PubMed ID: 16106441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in lung tissue from mouse, rat, hamster, and man.
    Richter E; Engl J; Friesenegger S; Tricker AR
    Chem Res Toxicol; 2009 Jun; 22(6):1008-17. PubMed ID: 19408892
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antisense evidence for nuclear factor-kappaB-dependent embryopathies initiated by phenytoin-enhanced oxidative stress.
    Kennedy JC; Memet S; Wells PG
    Mol Pharmacol; 2004 Sep; 66(3):404-12. PubMed ID: 15322231
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Redox- and non-redox-metal-induced formation of free radicals and their role in human disease.
    Valko M; Jomova K; Rhodes CJ; Kuča K; Musílek K
    Arch Toxicol; 2016 Jan; 90(1):1-37. PubMed ID: 26343967
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Free radical scavenging enzymes in fetal dysmorphogenesis among offspring of diabetic rats.
    Sivan E; Lee YC; Wu YK; Reece EA
    Teratology; 1997 Dec; 56(6):343-9. PubMed ID: 9485543
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fetal oxidative stress mechanisms of neurodevelopmental deficits and exacerbation by ethanol and methamphetamine.
    Wells PG; Bhatia S; Drake DM; Miller-Pinsler L
    Birth Defects Res C Embryo Today; 2016 Jun; 108(2):108-30. PubMed ID: 27345013
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of in vitro and in vivo developmental toxicity and pharmacokinetics of phenytoin in the rat.
    Beekhuijzen ME; Verhoef A; Klaassen R; Rompelberg CJ; Piersma AH
    Pharmacol Toxicol; 2000 Aug; 87(2):96-102. PubMed ID: 10989948
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oxidative DNA damage in the in utero initiation of postnatal neurodevelopmental deficits by normal fetal and ethanol-enhanced oxidative stress in oxoguanine glycosylase 1 knockout mice.
    Miller-Pinsler L; Pinto DJ; Wells PG
    Free Radic Biol Med; 2015 Jan; 78():23-9. PubMed ID: 25311828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.